Novartis Strikes $125M Deal For Chinese Vaccine Co.
Tianyuan, founded in 1994, is a privately owned company that does research on the prevention of bacterial diseases in addition to developing vaccines. The company had net sales of around $25 million in 2008, more than doubling its total of 2006, Novartis said.
"Novartis has a long-standing commitment to improving health care...
To view the full article, register now.